Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Drug Therapy"" wg kryterium: Temat


Tytuł :
Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients.
Autorzy :
Guo WF; Key Laboratory of Information Fusion Technology of Ministry of Education, School of Automation, Northwestern Polytechnical University, Xian 710072, China.; School of Electrical Engineering, Zhengzhou University, Zhengzhou 450001, China.
Zhang SW; Key Laboratory of Information Fusion Technology of Ministry of Education, School of Automation, Northwestern Polytechnical University, Xian 710072, China.
Feng YH; Key Laboratory of Information Fusion Technology of Ministry of Education, School of Automation, Northwestern Polytechnical University, Xian 710072, China.
Liang J; School of Electrical Engineering, Zhengzhou University, Zhengzhou 450001, China.
Zeng T; CAS Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy Science, Shanghai 200031, China.
Chen L; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy Science, Shanghai 200031, China.; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.; Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming 650223, China.; Key Laboratory of Systems Biology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Hangzhou 310024, China.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2021 Apr 19; Vol. 49 (7), pp. e37.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Algorithms*
Drug Therapy, Combination*
Breast Neoplasms/*drug therapy
Breast Neoplasms/*genetics
Lung Neoplasms/*drug therapy
Lung Neoplasms/*genetics
Precision Medicine/*methods
Breast Neoplasms/classification ; COVID-19/drug therapy ; COVID-19/genetics ; Datasets as Topic ; Drug Repositioning ; Drug Synergism ; Drug-Related Side Effects and Adverse Reactions ; Gene Expression Regulation, Neoplastic/genetics ; Genes, Neoplasm/genetics ; Humans ; Risk Assessment ; Workflow
Czasopismo naukowe
Tytuł :
Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting.
Autorzy :
Yuen CM; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.
Majidulla A; Interactive Research and Development, Karachi, Pakistan.
Jaswal M; Global Health Directorate, Indus Health Network, Karachi, Pakistan.
Safdar N; Global Health Directorate, Indus Health Network, Karachi, Pakistan.
Malik AA; Global Health Directorate, Indus Health Network, Karachi, Pakistan.; Interactive Research and Development (IRD) Global, Singapore.
Khan AJ; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.; Interactive Research and Development (IRD) Global, Singapore.
Becerra MC; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.
Keshavjee S; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.
Lu C; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Hussain H; Interactive Research and Development (IRD) Global, Singapore.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 07; Vol. 73 (5), pp. e1135-e1141.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Latent Tuberculosis*/drug therapy
Latent Tuberculosis*/prevention & control
Tuberculosis*/drug therapy
Tuberculosis*/prevention & control
Antitubercular Agents/therapeutic use ; Cost-Benefit Analysis ; Drug Therapy, Combination ; Humans ; Isoniazid/therapeutic use ; Rifampin/analogs & derivatives
Czasopismo naukowe
Tytuł :
Treatment-Resistant Depression: Approaches to Treatment.
Autorzy :
Kverno KS
Mangano E
Pokaż więcej
Źródło :
Journal of psychosocial nursing and mental health services [J Psychosoc Nurs Ment Health Serv] 2021 Sep; Vol. 59 (9), pp. 7-11. Date of Electronic Publication: 2021 Sep 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Treatment-Resistant*/drug therapy
Antidepressive Agents/therapeutic use ; Depression ; Drug Therapy, Combination ; Humans
Czasopismo naukowe
Tytuł :
Dabigatran-based dual antithrombotic therapy for patients with atrial fibrillation and ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Autorzy :
Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.
Galli M
Pokaż więcej
Źródło :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2021 Aug 27; Vol. 17 (6), pp. 443-444.
Typ publikacji :
Journal Article
MeSH Terms :
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Percutaneous Coronary Intervention*/adverse effects
ST Elevation Myocardial Infarction*/drug therapy
Anticoagulants/adverse effects ; Dabigatran/adverse effects ; Drug Therapy, Combination ; Fibrinolytic Agents/adverse effects ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial.
Autorzy :
Zeymer U; Klinikum Ludwigshafen and Institut für Herzinfarktforschung, Ludwigshafen, Germany.
Leiva O
Hohnloser SH
Steg PG
Oldgren J
Nickenig G
Gabor Kiss R
Ongen Z
Navarro Estrada J
Oude Ophuis T
Lip GYH
Nordaby M
Miede C
Ten Berg JM
Bhatt DL
Cannon CP
Pokaż więcej
Źródło :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2021 Aug 27; Vol. 17 (6), pp. 474-480.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Coronary Artery Disease*/drug therapy
Percutaneous Coronary Intervention*/adverse effects
ST Elevation Myocardial Infarction*/drug therapy
Anticoagulants/adverse effects ; Aspirin/therapeutic use ; Dabigatran/adverse effects ; Drug Therapy, Combination ; Fibrinolytic Agents/therapeutic use ; Humans ; Platelet Aggregation Inhibitors/adverse effects
Czasopismo naukowe
Tytuł :
A Clinical Update on Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke.
Autorzy :
Marsden K; Department of Neurology, University of Washington, Seattle, SA, USA. .
Mak HY; Department of Pharmacy, University of Washington, Seattle, SA, USA.
Crooks CP; Department of Neurology, University of Washington, Seattle, SA, USA.
Pankaj P; Department of Neurology, University of Washington, Seattle, SA, USA.
Nguyen T; Department of Neurology, University of Washington, Seattle, SA, USA.
Tirschwell D; Department of Neurology, University of Washington, Seattle, SA, USA.
Pokaż więcej
Źródło :
Current cardiology reports [Curr Cardiol Rep] 2021 Aug 19; Vol. 23 (10), pp. 145. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Brain Ischemia*/drug therapy
Brain Ischemia*/prevention & control
Ischemic Attack, Transient*/drug therapy
Ischemic Stroke*
Stroke*/drug therapy
Stroke*/prevention & control
Drug Therapy, Combination ; Humans ; Platelet Aggregation Inhibitors/therapeutic use ; Secondary Prevention
Czasopismo naukowe
Tytuł :
Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report.
Autorzy :
Onodera K; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: .
Onishi Y; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Inoue J; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tanaka Y; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yonha L; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ichikawa S; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Fukuhara N; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yokoyama H; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Murai K; Department of Hematology, Iwate Prefectural Central Hospital, Iwate, Japan.
Masamune A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Harigae H; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Aug; Vol. 27 (8), pp. 1230-1233. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Cord Blood Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Hepacivirus/genetics ; Humans
Czasopismo naukowe
Tytuł :
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus.
Autorzy :
Dehghan Manshadi SA; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Merat S; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohraz M; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Rasoolinejad M; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Sali S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mardani M; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Somi MH; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sedghi R; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Tayeri K; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Nikbin M; Iranian Charity for Patients with Liver Disease, Tehran, Iran.
Karimi J; Department of Infectious Diseases and Tropical Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Sharifi AH; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kalantari S; Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.
Norouzi A; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Science, Gorgan, Iran.
Merat D; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Malekzadeh Z; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mirminachi B; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Poustchi H; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Malekzadeh R; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Aug; Vol. 75 (8), pp. e14304. Date of Electronic Publication: 2021 May 17.
Typ publikacji :
Journal Article
MeSH Terms :
Coinfection*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Carbamates ; Drug Therapy, Combination ; Genotype ; HIV ; Humans ; Imidazoles ; Pyrrolidines ; Ribavirin/therapeutic use ; Sofosbuvir/therapeutic use ; Treatment Outcome ; Valine/analogs & derivatives
Czasopismo naukowe
Tytuł :
Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study.
Autorzy :
Håkansson KEJ; Department of Respiratory Medicine, Copenhagen University Hospital - Hvidovre, Hvidovre, Denmark.
Fjaellegaard K; Department of Respiratory Medicine, Zealand University Hospital Næstved, Næstved, Denmark.; Institute of Regional Health Research, University Southern Denmark, Odense, Denmark.
Browatzki A; Department of Respiratory Medicine, North Zealand Hospital, Hillerød, Denmark.
Dönmez Sin M; Department of Respiratory Medicine, Copenhagen University Hospital - Hvidovre, Hvidovre, Denmark.
Ulrik CS; Department of Respiratory Medicine, Copenhagen University Hospital - Hvidovre, Hvidovre, Denmark.; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło :
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2021 Jul 16; Vol. 16, pp. 2119-2127. Date of Electronic Publication: 2021 Jul 16 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Bronchiectasis*/diagnosis
Bronchiectasis*/drug therapy
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/drug therapy
Administration, Inhalation ; Adrenal Cortex Hormones/adverse effects ; Drug Therapy, Combination ; Humans ; Prospective Studies
Czasopismo naukowe
Tytuł :
Impact of the Inclusion of an Aminoglycoside to the Initial Empirical Antibiotic Therapy for Gram-Negative Bloodstream Infections in Hematological Neutropenic Patients: a Propensity-Matched Cohort Study (AMINOLACTAM Study).
Autorzy :
Albasanz-Puig A; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.
Gudiol C; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.; University of Barcelona, Barcelona, Spain.; Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
Puerta-Alcalde P; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.; Infectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
Ayaz CM; Hacettepe University School of Medicine, Ankara, Turkey.
Machado M; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Herrera F; Infectious Diseases Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina.
Martín-Dávila P; Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain.
Laporte-Amargós J; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.
Cardozo C; Infectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
Akova M; Hacettepe University School of Medicine, Ankara, Turkey.
Álvarez-Uría A; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Torres D; Infectious Diseases Section, Department of Medicine, Centro de Educación Médica e Investigaciones Clínicas, Buenos Aires, Argentina.
Fortún J; Infectious Diseases Department, Ramón y Cajal Hospital, Madrid, Spain.
García-Vidal C; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.; Infectious Diseases Department, Hospital Clínic i Provincial, Barcelona, Spain.
Muñoz P; Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Bergas A; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
Pomares H; Hematology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
Mercadal S; Hematology Department, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
Durà-Miralles X; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.
García-Lerma E; Biostatistics Unit, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Pallarès N; Biostatistics Unit, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Carratalà J; Infectious Disease Department, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.; Infections of the Respiratory Tract and in Immunocompromised Patients Research Group, Infectious Diseases and Transplantation Program, Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.; Spanish Network for Research in Infectious Disease, Instituto de Salud Carlos III, Madrid, Spain.; University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Jul 16; Vol. 65 (8), pp. e0004521. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Bacteremia*/drug therapy
Gram-Negative Bacterial Infections*/drug therapy
Sepsis*/drug therapy
Aminoglycosides/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study.
Autorzy :
Babich T; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Naucler P; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet and Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Valik JK; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet and Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
Giske CG; Department of Laboratory Medicine, Karolinska Institutet and Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Benito N; Infectious Diseases Unit, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau-Institut d'Investigació Biomèdica Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain.
Cardona R; Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Rivera A; Department of Microbiology, Hospital de la Santa Creu i Sant Pau-Institut d'Investigació Biomèdica Sant Pau, Barcelona, Spain.
Pulcini C; Université de Lorraine, APEMAC, F-54000, Nancy, France.; Université de Lorraine, CHRU-Nancy, Infectious Diseases Department, F-54000, Nancy, France.
Abdel Fattah M; Université de Lorraine, CHRU-Nancy, Infectious Diseases Department, F-54000, Nancy, France.
Haquin J; Université de Lorraine, CHRU-Nancy, Infectious Diseases Department, F-54000, Nancy, France.
MacGowan A; Department of Infection Sciences, Pathology Sciences Building, Southmead Hospital, Bristol, UK.
Grier S; Department of Infection Sciences, Pathology Sciences Building, Southmead Hospital, Bristol, UK.
Gibbs J; Department of Infection Sciences, Pathology Sciences Building, Southmead Hospital, Bristol, UK.
Chazan B; Infectious Diseases Unit, Emek Medical Center, Afula, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Yanovskay A; Infectious Diseases Unit, Emek Medical Center, Afula, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Ami RB; Sackler Faculty of Medicine, Tel Aviv University, Israel.; Infectious Diseases Unit, Sourasky Medical Center, Tel-Aviv, Israel.
Landes M; Infectious Diseases Unit, Sourasky Medical Center, Tel-Aviv, Israel.
Nesher L; Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel.
Zaidman-Shimshovitz A; Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel.
McCarthy K; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
Paterson DL; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
Tacconelli E; Division of Infectious Diseases, Tuebingen University Hospital, Tuebingen, Germany.
Buhl M; Division of Infectious Diseases, Tuebingen University Hospital, Tuebingen, Germany.
Mauer S; Division of Infectious Diseases, Tuebingen University Hospital, Tuebingen, Germany.
Rodriguez-Bano J; Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena/Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
Morales I; Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena/Departamento de Medicina, Universidad de Sevilla/Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain.
Oliver A; Servicio de Microbiología & Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain.
Ruiz de Gopegui E; Servicio de Microbiología & Unidad de Investigación, Hospital Universitario Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain.
Cano A; Infectious Diseases Unit, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain.
Machuca I; Infectious Diseases Unit, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Spain.
Gozalo-Marguello M; Microbiology Service, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Martinez LM; Microbiology Service, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Gonzalez-Barbera EM; Microbiology Department, La Fe University Hospital, Valencia, Spain.
Alfaro IG; Microbiology Department, La Fe University Hospital, Valencia, Spain.
Salavert M; Infectious Diseases Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
Beovic B; Department of Infectious Diseases, University Medical Centre, Ljubljana; Faculty of Medicine, University of Ljubljana, Slovenia.
Saje A; Department of Infectious Diseases, University Medical Centre, Ljubljana; Faculty of Medicine, University of Ljubljana, Slovenia.
Mueller-Premru M; Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia.
Pagani L; Infectious Diseases Unit, Bolzano Central Hospital, Bolzano, Italy.
Vitrat V; Infectious Diseases Unit, Annecy-Genevois Hospital Center (CHANGE), Annecy, France.
Kofteridis D; Infectious Disease Unit, Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece.
Zacharioudaki M; Infectious Disease Unit, Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece.
Maraki S; Infectious Disease Unit, Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Crete, Greece.
Weissman Y; Sackler Faculty of Medicine, Tel Aviv University, Israel.
Paul M; Infectious Diseases Unit, Rambam Health Care Campus, Haifa, Israel.
Dickstein Y; Infectious Diseases Unit, Rambam Health Care Campus, Haifa, Israel.
Leibovici L; Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.
Yahav D; Infectious Diseases Unit, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 15; Vol. 76 (8), pp. 2172-2181.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Bacteremia*/drug therapy
Pseudomonas Infections*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Humans ; Pseudomonas aeruginosa ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Outpatient continuous-infusion benzylpenicillin combined with either gentamicin or ceftriaxone for enterococcal endocarditis.
Autorzy :
Briggs S; Infectious Disease Unit, Auckland City Hospital, Auckland, New Zealand.
Broom M; Infectious Disease Unit, Auckland City Hospital, Auckland, New Zealand.
Duffy E; Infectious Disease Unit, Auckland City Hospital, Auckland, New Zealand.
Everts R; Infectious Disease Service, Nelson Bays Primary Health, Nelson, New Zealand.
Everts G; Department of Medicine, Tauranga Hospital, Tauranga, New Zealand.
Lowe B; Cardiology Unit, Auckland City Hospital, Auckland, New Zealand.
McBride S; Infectious Disease Unit, Middlemore Hospital, Auckland, New Zealand.
Bhally H; Infectious Disease Unit, North Shore Hospital and Waitakere Hospital, Auckland, New Zealand.
Pokaż więcej
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 15; Vol. 76 (8), pp. 2168-2171.
Typ publikacji :
Journal Article
MeSH Terms :
Endocarditis*/drug therapy
Endocarditis, Bacterial*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Ceftriaxone/therapeutic use ; Drug Therapy, Combination ; Gentamicins/therapeutic use ; Humans ; Outpatients ; Penicillin G ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Campylobacter fetus bacteremia and meningitis in an acute lymphoblastic leukemia patient undergoing maintenance therapy: a case report.
Autorzy :
Nakatani R; Department of Internal Medicine, St. Luke's International Hospital, 9-1, Akashi-cho, Chuo-ku, Tokyo, Japan. .
Shimizu K; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Matsuo T; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Koyamada R; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Mori N; Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Yamashita T; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Mori S; Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Jul 13; Vol. 21 (1), pp. 680. Date of Electronic Publication: 2021 Jul 13.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Campylobacter Infections*/blood
Campylobacter Infections*/cerebrospinal fluid
Campylobacter Infections*/diagnosis
Campylobacter Infections*/drug therapy
Foodborne Diseases*/complications
Foodborne Diseases*/diagnosis
Foodborne Diseases*/drug therapy
Foodborne Diseases*/microbiology
Meningitis, Bacterial*/diagnosis
Meningitis, Bacterial*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Campylobacter fetus/*isolation & purification
Ceftriaxone/*administration & dosage
Meropenem/*administration & dosage
Adult ; Anti-Bacterial Agents/administration & dosage ; Diagnosis, Differential ; Drug Therapy/methods ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Female ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
[A multicenter randomized controlled study of bismuth-containing quadruple therapy followed by Jing-Hua-Wei-Kang in the treatment of patients newly diagnosed with Helicobacter pylori infection and dyspepsia].
Autorzy :
Ma PP; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Meng LN; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Wang MT; Department of Gastroenterology, Jilin People's Hospital, Jilin 132012, China.
Jin HF; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Fan YH; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Zha AS; Department of Gastroenterology, the First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei 230031, China.
Huo XH; Department of Gastroenterology, the First Hospital of Hebei Medical University, Shijiazhuang 050023, China.
Chen DF; Department of Gastroenterology, the Chinese People's Liberation Army Medical Center, Chongqing 400042, China.
Cao ZQ; Department of Gastroenterology, the Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan 250011, China.
Tang XF; Department of Gastroenterology, Heilongjiang Provincial Hospital, Harbin 150030, China.
Yang P; Department of Gastroenterology, Xiangyin People's Hospital, Xiangyin 410500, China.
Shi ZH; Department of Gastroenterology, Wuhan No.1 Hospital, Wuhan 430033, China.
Li TW; Department of Gastroenterology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430006, China.
Meng J; Department of Gastroenterology, the Affiliated Hospital of Hebei University, Baoding 071030, China.
Gan C; the First Department of Gastroenterology, the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China.
Chen GX; Department of Gastroenterology, Xuzhou No.1 People's Hospital, Xuzhou 221002, China.
Sha WH; Department of Gastroenterology, Guangdong Provincial People's Hospital, Guangzhou 510080, China.
Du Q; Department of Gastroenterology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
Li Y; Department of Gastroenterology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Lyu B; Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University, Key Laboratory for Pathophysiological Research on Digestive System Diseases of Zhejiang Province, Hangzhou 310060, China.
Pokaż więcej
Źródło :
Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2021 Jul 13; Vol. 101 (26), pp. 2060-2065.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Dyspepsia*/drug therapy
Helicobacter Infections*/drug therapy
Helicobacter pylori*
Amoxicillin/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Bismuth/therapeutic use ; China ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
Autorzy :
Eikelboom JW; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: .
Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.
Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Bosch J; Population Health Research Institute, Hamilton Ontario, Canada; School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada.
Connolly SJ; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Anand SS; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Avezum A; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Berkowitz SD; Bayer US, LLC, Whippany, New Jersey, USA.
Branch KRH; University of Washington Medical Center, Seattle, Washington, USA.
Dagenais GR; Institut Universitaire de Cardiologie et Pneumologie de Québec, Université Laval, Québec, Québec, Canada.
Félix C; Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito, Ecuador.
Guzik TJ; Department of Internal and Agricultural Medicine, Jagiellonian University, Collegium Medicum, Krakow, Poland; British Heart Foundation Centre for Cardiovascular Research, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Hart RG; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada.
Maggioni AP; Italian Association of Hospital Cardiologists Research Center, Florence, Italy.
Muehlhofer E; Bayer AG, Wuppertal, Germany.
Sharma M; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Shestakovska O; Population Health Research Institute, Hamilton Ontario, Canada.
Yusuf S; Population Health Research Institute, Hamilton Ontario, Canada; Hamilton Health Sciences, Hamilton, Ontario, Canada; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Pokaż więcej
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Jul 06; Vol. 78 (1), pp. 14-23.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Aspirin*/administration & dosage
Aspirin*/adverse effects
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/mortality
Peripheral Arterial Disease*/diagnosis
Peripheral Arterial Disease*/drug therapy
Peripheral Arterial Disease*/mortality
Rivaroxaban*/administration & dosage
Rivaroxaban*/adverse effects
Aged ; Diabetes Mellitus/epidemiology ; Drug Therapy, Combination ; Factor Xa Inhibitors/administration & dosage ; Factor Xa Inhibitors/adverse effects ; Female ; Heart Failure/epidemiology ; Humans ; Male ; Outcome Assessment, Health Care ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/adverse effects ; Risk Assessment ; Risk Factors ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Impact of Optimal Medical Therapy on 10-Year Mortality After Coronary Revascularization.
Autorzy :
Kawashima H; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland; Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: https://twitter.com/HideyukiKawash2.
Serruys PW; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland; National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address: .
Ono M; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland; Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Hara H; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland; Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
O'Leary N; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland.
Mack MJ; Department of Cardiothoracic Surgery, Baylor Scott and White Health, Dallas, Texas, USA.
Holmes DR; Department of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Morice MC; Hôpital Privé Jacques Cartier, Ramsay Générale de Santé, Massy, France.
Head SJ; Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Kappetein AP; Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Thuijs DJFM; Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.
Milojevic M; Department of Cardiothoracic Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands; Department of Cardiac Surgery and Cardiovascular Research, Dedinje Cardiovascular Institute, Belgrade, Serbia.
Noack T; University Department of Cardiac Surgery, Heart Centre Leipzig, Leipzig, Germany.
Mohr FW; University Department of Cardiac Surgery, Heart Centre Leipzig, Leipzig, Germany.
Davierwala PM; University Department of Cardiac Surgery, Heart Centre Leipzig, Leipzig, Germany.
Sharif F; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland.
McEvoy JW; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland.
Onuma Y; Department of Cardiology, National University of Ireland, Galway, Galway, Ireland.
Pokaż więcej
Corporate Authors :
SYNTAX Extended Survival Investigators
Źródło :
Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 Jul 06; Vol. 78 (1), pp. 27-38.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronary Artery Bypass*/adverse effects
Coronary Artery Bypass*/methods
Coronary Artery Disease*/diagnosis
Coronary Artery Disease*/drug therapy
Coronary Artery Disease*/mortality
Coronary Artery Disease*/surgery
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/instrumentation
Percutaneous Coronary Intervention*/methods
Adrenergic beta-Antagonists/*administration & dosage
Angiotensin Receptor Antagonists/*administration & dosage
Angiotensin-Converting Enzyme Inhibitors/*administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors/*administration & dosage
Platelet Aggregation Inhibitors/*administration & dosage
Coronary Vessels/diagnostic imaging ; Coronary Vessels/pathology ; Coronary Vessels/surgery ; Drug Therapy, Combination/methods ; Drug Therapy, Combination/statistics & numerical data ; Drug-Eluting Stents ; Female ; Humans ; Male ; Middle Aged ; Mortality ; Postoperative Period ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C.
Autorzy :
Havens JR; Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky, USA .
Schaninger T; Infectious Diseases, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Fraser H; Population Health Sciences, University of Bristol, Bristol, UK.
Lofwall M; Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Staton M; Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Young AM; Epidemiology, University of Kentucky College of Public Health, Lexington, Kentucky, USA.
Hoven A; Infectious Diseases, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Walsh SL; Behavioral Science, University of Kentucky College of Medicine, Lexington, Kentucky, USA.
Vickerman P; Population Health Sciences, University of Bristol, Bristol, UK.; London School of Hygiene & Tropical Medicine, London, UK.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 Jul 05; Vol. 11 (7), pp. e041490. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Clinical Trial, Phase IV; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Carbamates ; Drug Therapy, Combination ; Female ; Genotype ; Hepacivirus/genetics ; Heterocyclic Compounds, 4 or More Rings ; Humans ; Kentucky/epidemiology ; Pregnancy ; Sofosbuvir/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal.
Autorzy :
Zheng S; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Aldahdooh J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Shadbahr T; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Wang Y; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Aldahdooh D; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Bao J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki FI-00290, Finland.
Wang W; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Tang J; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki FI-00290, Finland.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2021 Jul 02; Vol. 49 (W1), pp. W174-W184.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Algorithms*
Databases, Factual*
Drug Evaluation, Preclinical*
Drug Therapy, Combination*
Internet*
COVID-19/drug therapy ; Data Visualization ; Datasets as Topic ; Drug Synergism ; Hemorrhagic Fever, Ebola/drug therapy ; Humans ; Machine Learning ; Malaria/drug therapy ; Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
Autorzy :
Totsuka M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Honda M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kanda T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Ishii T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Matsumoto N; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Yamana Y; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kaneko T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Mizutani T; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Takahashi H; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kumagawa M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Sasaki R; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Masuzaki R; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Kanezawa S; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Nirei K; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Yamagami H; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Matsuoka S; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Ohnishi H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Japan.
Okamoto H; Division of Virology, Department of Infection and Immunity, Jichi Medical University School of Medicine, Japan.
Moriyama M; Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Jul 01; Vol. 60 (13), pp. 2061-2066. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Hepacivirus*/genetics
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Adult ; Aged ; Antiviral Agents/therapeutic use ; Benzimidazoles ; Drug Combinations ; Drug Therapy, Combination ; Genotype ; Humans ; Japan ; Liver Cirrhosis/drug therapy ; Male ; Pyrrolidines ; Quinoxalines ; Sulfonamides
Czasopismo naukowe
Tytuł :
Model-based meta-analysis of the time to first acute urinary retention or benign prostatic hyperplasia-related surgery in patients with moderate or severe symptoms.
Autorzy :
D'Agate S; Clinical Pharmacology & Therapeutics Group, University College London, London, WC1H 9JP, UK.
Chavan C; Global Medical Urology, GlaxoSmithKline, Mumbai, Maharashtra, 400093, India.
Manyak M; Global Medical Urology, GlaxoSmithKline, Philadelphia, PA, 19112, USA.
Palacios-Moreno JM; Global Medical Urology, GlaxoSmithKline, Tres Cantos, 28760, Spain.
Oelke M; Department of Urology, St Antonius Hospital, Gronau, D-48599, Germany.
Michel MC; Department of Pharmacology, Johannes Gutenberg University, Mainz, 55131, Germany.
Roehrborn CG; Department of Urology, Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Della Pasqua O; Clinical Pharmacology & Therapeutics Group, University College London, London, WC1H 9JP, UK.; Clinical Pharmacology Modelling & Simulation, GSK House, London, TW8 9GS, UK.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Jul; Vol. 87 (7), pp. 2777-2789. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Prostatic Hyperplasia*/complications
Prostatic Hyperplasia*/drug therapy
Urinary Retention*/chemically induced
Urinary Retention*/drug therapy
Azasteroids/therapeutic use ; Drug Therapy, Combination ; Humans ; Male ; Sulfonamides/therapeutic use ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies